ロード中...
Interleukin-33 drives hepatic fibrosis through activation of hepatic stellate cells
Liver fibrosis is a consequence of chronic liver disease, causing morbidity and mortality. Interleukin-33 (IL-33) is a critical mediator of inflammation, which may be involved in the development of liver fibrosis. Here, we investigated the role of IL-33 in human patients and experimental bile-duct l...
保存先:
| 出版年: | Cell Mol Immunol |
|---|---|
| 主要な著者: | , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Nature Publishing Group UK
2017
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6052839/ https://ncbi.nlm.nih.gov/pubmed/28194023 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/cmi.2016.63 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|